The development of a dense gas solvent exchange process for the impregnation of pharmaceuticals into porous chitosan

International Journal of Pharmaceutics

Volumn 391, Issue 1-2, 2010, Pages 187-196

  Ji, Chengdong ^a   Barrett, Angela ^b   Poole Warren, Laura A ^b   Foster, Neil R ^b   Dehghani, Fariba ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Amorphous; Camptothecin; Chitosan; Impregnation by dense gas CO2; Porosity

Indexed keywords

CAMPTOTHECIN; CHITOSAN; GRISEOFULVIN; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; GRAVIMETRY; HYDROPHILICITY; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; X RAY DIFFRACTION;

CAMPTOTHECIN; CARBON DIOXIDE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CRYSTALLIZATION; DRUG CARRIERS; DRUG COMPOUNDING; GRISEOFULVIN; HYDROGELS; PARTICLE SIZE; POROSITY; PRESSURE; SOLUBILITY; SOLVENTS;

EID: 77952884208     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.006     Document Type: Article

References (54)

1. Acarturk F., Sencan A., Celebi N. Enhancement of the dissolution of spironolactone with chitosan and low-molecular weight gelatin. S.T.P. Pharm. Sci. 1993, 3:369-373.
2. Ahmed H., Buckton G., Rawlins D. Crystallization of partially amorphous griseofulvin in water vapor: determination of kinetic parameters using isothermal heat conduction microcalorimetry. Int. J. Pharm. 1998, 167:139-145.
3. Alexis F., Venkatraman S.S., Rath S.K., Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrixes. J. Control. Release 2004, 98:67-74.
4. 2. Biomaterials 2009, 30:1-7.
5. Bergese P., Colombo I., Gervasoni D., Depero L. Melting of nanostructured drugs embedded into a polymeric matrix. J. Phys. Chem. B 2004, 108:15488-15493.
6. Busby A.J., Morley K.S., Roberts C.J., Watson M.S., Webb P.B., Wong B., Zhang J., Kokturk G., Howdle S.M. Polymers, biomaterilas and supercritical fluids. Proceedings of the 8th Meeting on Supercritical Fluids, International Society for the Advancement of Supercritical Fluids (ISASF) 2002.
7. Calvino-Casilda V., Lopez-Peinado A.J., Vaganova E., Yitzchaik S., Pacios I.E., Pierola I.F. Porosity inherent to chemically crosslinked polymers. Poly(N-vinylimidazole) hydrogels. J. Phys. Chem. B 2008, 112:2809-2817.
8. Carli F., Colombo I., Magarotto L. Proceedings of the 13th International Symposium on Controlled Release of Bioactive Materials 1986, 193. The Controlled Release Society, Minneapolis, MN. I. Chaudy (Ed.).
9. 2. Adv. Mater. Weinheim 2001, 13:1111-1114.
10. Craig D.Q.M., Reading M. Thermal analysis of pharmaceuticals. Pharmaceutical Application of DSC 2007, 416. CRC Press, Boca Raton. D.Q.M. Craig (Ed.).
11. Dong N., Xue S.-F., Zhu Q.-J., Tao Z., Zhao Y., Yang L.-X. Cucurbit[n]urils (n=7, 8) binding of camptothecin and the effects on solubility and reactivity of the anticancer drug. Supramol. Chem. 2008, 20:659-665.
12. Duarte A.R.C., Costa M.S., Simplicio A.L., Cardoso M.M., Duarte C.M.M. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int. J. Pharm. 2006, 308:168-174.
13. Gao P. Amorphous pharmaceutical solids: characterization, stabilization, and development of marketable formulations of poorly soluble drugs with improved oral absorption. Mol. Pharm. 2008, 5:903-904.
14. Gong K., Darr J.A., Rehman I.U. Supercritical fluid assisted impregnation of indomethacin into chitosan thermosets for controlled release applications. Int. J. Pharm. 2006, 315:93-98.
15. Gurusamy S., Kumar V., Mishra D.N. Preparation, characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Chem. Pharm. Bull. 2006, 54:1102-1106.
16. He W., Guo X., Zhang M. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone. Int. J. Pharm. 2008, 356:82-87.
17. Hertzberg R.P., Caranfa M.J., Hecht S.M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 1989, 28:4629-4638.
18. Huang H.-N., Li T.-L., Chan Y.-L., Chen C.-L., Wu C.-J. Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 2009, 30:6017-6025.
19. 2-alcohol systems (methanol, ethanol, 2-methoxyethanol and 2-ethoxyethanol). Fluid Phase Equilib. 2001, 185:219-230.
20. Jung J., Leboeuf F., Clavier J.Y., Perrut M. Equipment design for supercritical fluid micronization in compliance with GMP for pharmaceutical applications. Proceedings of the Fourth International Symosium in High-Pressure Process Technology and Chemical Engineering 2002.
21. Kang H.-W., Tabata Y., Ikada Y. Effect of porous structure on the degradation of freeze-dried gelatin hydrogels. J. Bioact. Compat. Polym. 1999, 14:331-343.
22. Kazarian S.G., Chan A. Molecular states of drugs in formulations processed with supercritical fluids: in situ ATR-IR spectroscopy and spectroscopic imaging study. PMSE Prepr. 2003, 89:628-629.
23. 2 and polymer phase. J. Supercrit. Fluids 1998, 13:107-112.
24. 2 anti-solvent precipitation. J. Supercrit. Fluids 2009, 48:176-182.
25. Ladet S., David L., Domard A. Multi-membrane hydrogels. Nature (London, U.K.) 2008, 452:76-79.
26. 2 technique for beta-galactosidase immobilization in polystyrene microchannels. Biomacromolecules 2008, 9:1027-1034.
27. 2-in-water emulsion-templated poly(vinyl alcohol) hydrogels using poly(vinyl acetate)-based surfactants. Macromolecules 2007, 40:1955-1961.
28. Lee P.-W., Peng S.-F., Su C.-J., Mi F.-L., Chen H.-L., Wei M.-C., Lin H.-J., Sung H.-W. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 2008, 29:742-751.
29. Liu C.-X., Hou W.-G., Li Y., Li L.-F. Synthesis and characterization of camptothecin intercalated into Mg/Al layered double hydroxide. Chin. J. Chem. 2008, 26:1806-1810.
30. 2: evaluation of drug stability and drug-matrix interactions. J. Supercrit. Fluids 2009, 48:56-63.
31. Lovrecich, M., 1995. Supported drugs with increased dissolution rate, and a process for their preparation, US 5449 521.
32. Ma P.X. Biomimetic materials for tissue engineering. Adv. Drug Deliv. Rev. 2008, 60:184-198.
33. Madihally S.V., Matthew H.W.T. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999, 20:1133-1142.
34. Maestrelli F., Zerrouk N., Chemtob C., Mura P. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int. J. Pharm. 2004, 271:257-267.
35. McKelvey S.A., Koros W.J. Phase separation, vitrification, and the manifestation of macrovoids in polymeric asymmetric membranes. J. Membr. Sci. 1996, 112:29-39.
36. Mura P., Zerrouk N., Mennini N., Maestrelli F., Chemtob C. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 2003, 19:67-75.
37. Nambu N., Sawayanagi Y., Nagai T. Dissolution properties and bioavailability of poorly soluble drugs from ground mixtures with chitin or chitosan. Expo.-Congr. Int. Technol. Pharm., 3rd. 1983, 1:259-267.
38. Natu M.V., Gil M.H., de Sousa H.C. Supercritical solvent impregnation of poly(e-caprolactone)/poly(oxyethylene-b-oxypropylene-b-oxyethylene) and poly(e-caprolactone)/poly(ethylene-vinyl acetate) blends for controlled release applications. J. Supercrit. Fluids 2008, 47:93-102.
39. Osman Z., Arof A.K. FTIR studies of chitosan acetate based polymer electrolytes. Electrochim. Acta 2003, 48:993-999.
40. Overhoff K.A., Johnston K.P., Williams R.O. Improvement of dissolution rate of poorly water soluble drugs using a new particle engineering process: spray freezing into liquid. ACS Symp. Ser. 2006, 924:305-319.
41. Puttipipatkhachorn S., Nunthanid J., Yamamoto K., Peck G.E. Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. J. Control. Release 2001, 75:143-153.
42. Quirk R.A., France R.M., Shakesheff K.M., Howdle S.M. Supercritical fluid technologies and tissue engineering scaffolds. Curr. Opin. Solid State Mater. Sci. 2005, 8:313-321.
43. Saetern A.M., Skar M., Braaten A., Brandl M. Camptothecin-catalyzed phospholipid hydrolysis in liposomes. Int. J. Pharm. 2005, 288:73-80.
44. Sawayanagi Y., Nambu N., Nagai T. Pharmaceutical interactions in dosage forms and processing, XXXIX. Enhancement of dissolution properties of prednisolone from ground mixtures with chitin or chitosan. Chem. Pharm. Bull. 1983, 31:2507-2509.
45. Shih, H.-H., Lee, K.-R., Lai, H.-M., Tsai, C.-C., Chang, Y.-C., 2003. Production of porous biodegradable polymers using supercritical fluid, US 2003064156.
46. Thacharodi D., Panduranga Rao K. Collagen-chitosan composite membranes controlled transdermal delivery of nifedipine and propranolol hydrochloride. Int. J. Pharm. 1996, 134:239-241.
47. Thacharodi D., Panduranga Rao K. Rate-controlling biopolymer membranes as transdermal delivery systems for nifedipine: development and in vitro evaluations. Biomaterials 1996, 17:1307-1311.
48. Thacharodi D., Rao P. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propanolol hydrochloride. Biomaterials 1995, 16:145-148.
49. Thassu D., Deleers M., Pathak Y. Nanoparticulate Drug Delivery Systems 2007, CRC Press, p. 64.
50. Thomas J. Australian Prescription Products Guide 2001, p. 1.
51. USP-NF, The United States Pharmacopedia-National Formulary (USP-NF).
52. VandeVord P.J., Matthew H.W.T., DeSilva S.P., Mayton L., Wu B., Wooley P.H. Evaluation of the biocompatibility of a chitosan scaffold in mice. J. Biomed. Mater. Res. 2002, 59:585-590.
53. Wang A., Ao Q., Wei Y., Gong K., Liu X., Zhao N., Gong Y., Zhang X. Physical properties and biocompatibility of a porous chitosan-based fiber-reinforced conduit for nerve regeneration. Biotechnol. Lett. 2007, 29:1697-1702.
54. Yurkovetskiy A.V., Hiller A., Syed S., Yin M., Lu X.M., Fischman A.J., Papisov M.I. Synthesis of a macromolecular camptothecin conjugate with dual phase drug release. Mol. Pharm. 2004, 1:375-382.